| |
|
|
|
|
 |
2011/11 |
Dr. Wichittra Tassaneeyakul to present abstract at Association for Molecular Pathology 2011 Annual Meeting at Texas, USA Abstract Title: HLA-B*5801, a strong pharmacogenetic marker for severe cutaneous adverse drug reaction caused by allopurinol in Thai population |
|
|
| |
|
|
|
|
|
2011/11 |
The 10th Chinese Laboratory Medicine Conference |
< more > |
|
| |
|
|
|
|
|
2011/04 |
Depakote Class Action Lawsuit Filed Over Birth Defect Risks |
< more > |
|
| |
|
|
|
|
|
2011/03 |
Generic Dilantin Lawsuit Filed Over Stevens-Johnson Syndrome Reaction |
< more > |
|
| |
|
|
|
|
|
2011/03 |
Pharmigene participates in a life saving prospective study that is published in the latest New England Journal of Medicine. |
< more > |
|
| |
|
|
|
|
|
2011/03 |
Pharmacogenomics becomes Standard in over 50 Hospitals throughout Taiwan through use of New Genetic Screening Kit. |
< more > |
|
| |
|
|
|
|
|
2011/03 |
Pharmigene receives 3rd BioSpectrum Asia-Pacific Emerging Company of the Year Award 2011 |
< more > |
|
| |
|
|
|
|
|
2011/01 |
Verdict of $142.1M in Lawsuit Over Neurontin |
< more > |
|
| |
|
|
|
|
|
2011/01 |
Dilantin Stevens-Johnson Syndrome Lawsuit Filed by Three People |
< more > |
|
| |
|
|
|
|
|
2010/11 |
| See us at 2010 Association for Molecular Pathology (AMP) Annual Meeting. |
| We invite you to see us at the Association for Molecular Pathology (AMP) 16th Annual Meeting and Exhibits (Booth #1222) from 17th to 20th November, 2010, at the San Jose McEnery Convention Center, San Jose, CA. |
|
< more > |
|
| |
|
|
|
|
|
2010/11 |
| Pharmigene Collaborates to Battle SJS and TENS in United States. |
| Pharmigene today announced the licensing of its patented and patent-pending intellectual property to Mayo Medical Laboratories to develop in-house genetic tests. The tests are being designed for use in detecting the presence of key genetic alleles in individual patients being considered for treatment with drugs that have been linked to the development of SJS and TENS. |
|
< more > |
|
| |
|
|
|
|
|
2010/11 |
| Pharmigene Secures Patents Related to Genetic-Based Methods to Fight SJS and TENS in United States, Europe, Australia, Singapore and Taiwan. |
| Pharmigene today announced it has been granted patents in the United States, Europe, Australia, Singapore and Taiwan. The patents cover methods to detect the presence of key genetic alleles in individual patients being considered for treatment with drugs that have been linked to the development of adverse drug reactions including SJS and TENS. |
|
< more > |
|
| |
|
|
|
|
|
2010/09 |
SJS Lawsuit Garners Victim $21 Million |
< more > |
|
| |
|
|
|
|
|
2010/09 |
Making a Case for the Cost-Effectiveness of Pharmacogenetic Testing in Taiwan. |
|
|
| |
|
|
|
|
|
2010/08 |
| European patent for the “Risk Assessment for Adverse Drug Reactions”was issued as Patent number: EP1697539. |
| This invention relates to methods for predicting the risk of an individual for adverse drug reactions. |
| It includes the presence of HLA-B*1502 for Carbamazepine induced SJS/TEN and the presence of HLA-B*5801 for Allopurinol induced SJS/TEN. |
| Inventors: Chen, Yuan-Tsong; Hung, Shuen-Iu; Chung, Wen-Hung and Wu, Jer-Yuarn |
| Pharmignen, Inc. has officially got the exclusive licensing from Academia Sinica. |
|
< more > |
|
| |
|
|
|
|
|
2010/07 |
| News from 2010 AACC Annual Meeting: |
| A collaboration project led by Academia Sinica, Pharmigene, and many top scientists/physicians in Taiwan receives National Academy Clinical Biochemistry Distinguished Abstract Award. Title: "A Prospective Study of the Use of HLA-B*1502 Genotyping in Preventing Carbamazepine- induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis." |
*Oral Presentation:
Tuesday, July 27, 4:15pm-4:35pm, Rm.213B of the Anaheim Convention Center by Dr. Luke Chen, CEO, Pharmigene. |
*Poster Presentation:
C-23 Wednesday, July 28, 10am-12:30pm. Topic: Clinical Studies/Outcome |
|
< more > |
|
| |
|
|
|
|
|
2010/05 |
Stevens-Johnson Syndrome Lawsuit Over Generic Dilantin Use Filed |
< more > |
|
| |
|
|
|
|
|
2010/05 |
Lawsuit Alleges Stevens Johnson Syndrome from Bipolar Drug |
< more > |
|
| |
|
|
|
|
|
2010/03 |
| Research presented at American College of Cardiology annual meeting: |
| Warfarin- Medco, Mayo Clinic study reveals using a simple genetic test reduces hospitalization rates by nearly a third for patients on widely prescribed blood thinner |
|
< more > |
|
| |
|
|
|
|
|
2010/01 |
SJS Dilantin: Wrongful Death Lawsuit |
< more > |
|
| |
|
|
|
|
|
2009/08 |
Stevens-Johnson Syndrome Malpractice Lawsuit Results in $6M Verdict |
< more > |
|
| |
|
|
|
|
|
2009/01 |
Wife files lawsuit against drug maker |
< more > |
|
| |
|
|
|
|
|
2008/08 |
Suit Over Phenytoin Names 10 Defendants in Woman’s Death |
< more > |
|
| |
|
|
|
|
